Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease

Agriculture & Biology

• influenza vaccination 100%
• influenza vaccines 86%
• kidney diseases 74%
• dosage 30%
• confidence interval 26%
• vaccination 21%
• myositis 15%
• urticaria 14%
• encephalopathy 13%
• anaphylaxis 12%
• seizures 10%
• pain 10%
• limbs (animal) 9%
• diarrhea 9%
• vaccines 8%
• syncope 8%
• cellulitis 7%
• nausea 6%
• vomiting 6%
• influenza 5%
• clinical trials 5%
• fever 4%
• kidneys 3%
• methodology 1%

Medicine & Life Sciences

• Influenza Vaccines 66%
• Human Influenza 53%
• Chronic Kidney Failure 51%
• Vaccination 46%
• Safety 33%
• Confidence Intervals 14%
• Angioedema 12%
• Myositis 11%
• Urticaria 11%
• Myalgia 10%
• Anaphylaxis 10%
• Exanthema 9%
• Brain Diseases 9%
• Diarrhea 8%
• Seizures 7%
• SHORT syndrome 7%
• Vaccines 7%
• Extremities 7%
• Data Systems 6%
• Cellulitis 5%
• Pain 5%
• Syncope 5%
• Propensity Score 5%
• Mortality 4%
• Proportional Hazards Models 4%
• Nausea 4%
• Vomiting 4%
• Risk Assessment 4%
• Population 3%
• Fever 3%
• Clinical Trials 3%
• Kidney 2%
• Therapeutics 0%

Social Sciences

• end stage renal disease 88%
• vaccination 65%
• contagious disease 57%
• adverse events 16%
• confidence 15%
• seizure 9%
• pain 7%
• mortality 6%
• recipient 6%
• Clinical Trials 4%
• Group 2%
• cause 2%
• event 2%